Ownership history in Capula Management Ltd · 25 quarters on record
This page tracks every 13F SEC filing in which Capula Management Ltd reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 500 | +200 | +66.7% | 0.00% | $386K | $770.94 |
| 2025 Q4 | UNCHANGED | 300 | — | 0% | 0.00% | $232K | $770.94 |
| 2025 Q3 | REDUCED | 300 | -100 | -25.0% | 0.00% | $169K | $560.89 |
| 2025 Q3 | ADDED | 400 | +219 | +121.0% | 0.00% | $225K | $560.89 |
| 2025 Q3 | REDUCED | 181 | -59 | -24.6% | 0.00% | $102K | $560.89 |
| 2025 Q2 | REDUCED | 240 | -60 | -20.0% | 0.00% | $126K | $522.92 |
| 2025 Q2 | ADDED | 300 | +100 | +50.0% | 0.00% | $158K | $522.92 |
| 2025 Q2 | REDUCED | 200 | -100 | -33.3% | 0.00% | $105K | $522.92 |
| 2025 Q1 | ADDED | 300 | +109 | +57.1% | 0.00% | $190K | $630.78 |
| 2025 Q1 | ADDED | 191 | +157 | +461.8% | 0.00% | $121K | $630.78 |
As of 2025 Q4 — sorted by position size